Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma

Anticancer Research

Volumn 27, Issue 2, 2007, Pages 1199-1205

  De Abreu, Francine Blumental ^a   Pirolo Jr , Leandro ^b   Canevari, Renata De Azevedo ^a   Rosa, Fabíola Encinas ^a   Neto, Francisco Alves Moraes ^c   Caldeira, José Roberto Fígaro ^c   Rainho, Claudia Aparecida ^a   Rogatto, Silvia Regina ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c Amaral Carvalho Hospital   (Brazil)

Author keywords

CAG n repeats; Androgen receptor gene; Breast carcinoma; Fibroadenoma; Hyperplasia

Indexed keywords

ANDROGEN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST HYPERPLASIA; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FIBROADENOMA; HUMANS; HYPERPLASIA; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS;

EID: 34247150453     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Schnitt SJ: Benign breast disease and cancer risk: morphology and beyond. Am J Surg Pathol 27: 836-841, 2003.
2. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson Jo, Blake C, Tlsty T, Vachon CM, Melton LJ and Visscher DW: Benign breast disease and the risk of breast cancer. N Engl J Med 353: 229-237, 2005.
3. Dupont WD and Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312: 146-151, 1985.
4. Carter CL, Corle DK, Micozzi MS, Schatzkin A and Taylor PR: A prospective study of the development of breast cancer in 16, 692 women with benign breast disease. Am J Epidemiol 128: 467-477, 1988.
5. Palli D, Del Turco MR, Simoncini R and Bianchi S: Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int J Cancer 47: 703-706, 1991.
6. London SJ, Connolly JL, Schnitt SJ and Colditz GA: A prospective study of benign breast disease and the risk of breast cancer. J Am Med Assoc 267: 941-944, 1992.
7. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Robin GL and Gersell D: The Cancer and Steroid Hormone Group: histologic types of benign breast disease and the risk of breast cancer. Cancer 69: 1408-1414, 1992.
8. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer Jr WD, Rados MS and Schuyler PA: Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 331: 10-15, 1994.
9. Fitzgibbons PL, Henson DE and Hutter RVP: Benign breast changes and the risk for subsequent breast cancer. Arch Pathol Lab Med 122: 1053-1055, 1998.
10. Moskowitz M, Gartside P, Wirman JA and McLaughlin C: Proliferative disorders of the breast as risk factors for breast cancer in a self-selected screened population: pathologic markers. Radiology 134: 289-291, 1980.
11. Levi F, Randimbison L, Te VC and La Vecchia C: Incidence of breast cancer in women with fibroadenoma. Int J Cancer 57: 681-683, 1994.
12. Ciatto S, Bonardi R, Zappa M and Giorgi D: Risk of breast cancer subsequent to histological or clinical diagnosis of fibroadenoma - retrospective longitudinal study of 3938 cases. Ann Oncol 8: 297-300, 1997.
13. Levshin V, Pikhut P, Yakovleva I and Lazarev I: Benign lesions and cancer of the breast. Eur J Cancer Prev 7(Suppl I): S37-40, 1998.
14. Franco N, Picard SF, Mege F, Arnould L and Lizard-Nacol S: Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations. Cancer Res 61: 7955-7958, 2001.
15. Baxter SW, Choong DY, Eccles DM and Campbell IG: Polymorphic variation in CYP19 and the risk of breast cancer. Carcinogenesis 22: 347-349, 2001.
16. Beato M, Herrlich P and Schutz G: Steroid hormone receptors: many actors in search of a plot. Cell 15: 851-857, 1995.
17. Jänne OA, Palvimo JJ, Kallio P and Mehto M: Androgen receptor and mechanism of androgen action. Ann Med 25: 83-89, 1993.
18. Luke MC and Coffey DS: The male sex accessory tissues: structure, androgen action, and physiology. In: The Physiology of Reproduction. Knobil E and Neill JD (eds.). Raven Press, New York, pp. 1435-1487, 1994.
19. Chamberlain NL, Driver ED and Miesfeld RL: The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22: 3181-3186, 1994.
20. n-expanded neuronopathies. Hum Mol Genet 4: 523-527, 1995.
21. Giguère Y, Dewailly E, Brisson J, Ayotte P, Laflamme N, Demers A, Forest VI, Dodin S, Robert J and Rousseau F: Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res 61: 5869-5874, 2001.
22. Haiman CA, Brown M, Hanksinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW and Hunter DJ: The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study. Cancer Res 62: 1045-1049, 2002.
23. Liede A, Zhang W, Matsuda MLL, Tan A and Narod SA: Androgen receptor gene polymorphism and breast cancer susceptibility in the Philippines. Cancer Epidemiol Biomarkers Prev 12: 848-852, 2003.
24. Anghel A, Raica M, Marian C, Ursoniu S and Mitrasca O: Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer. J Cancer Res Clin Oncol 132: 727-733, 2006.
25. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA and Easton DF: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8: 843-854, 1999.
26. Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL and Chenevix-Trench G: Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J Natl Cancer Inst 91: 961-966, 1999.
27. Given HF, Radbourne R, Oag H, Merritt S, Barclay E, Hanby AM, Lamlum H, McGrath J, Curran C and Tomlinson IPM: The androgen recepton exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer. Eur J Cancer 36: 533-534, 2000.
28. Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T and Eeles RA: CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer 85: 36-40, 2001.
29. Menin C, Banna GL, De Salvo G, Lazzarotto V, De Nicolo A, Agata S, Montagna M, Sordi G, Nicoletto O, Chieco-Bianchi L and D'Andrea E: Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett 168: 31-36, 2001.
30. n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 12: 127-135, 2003.
31. Yu H, Bharaj B, Vassilikos EJK, Giai M and Diamandis EP: Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer. Breast Cancer Res Treat 59: 153-161, 2000.
32. Elhaji YA, Gottlieb B, Lumbroso R, Beitel LK, Foulkes WD, Pinsky L and Trifiro MA: The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40. Breast Cancer Res Treat 70: 109-116, 2001.
33. Kasami M, Gobbi H, Dupont WD, Simpson JF, Page DL and Vnencak-Jones CL: Androgen receptor CAG repeat lengths in ductal carcinoma in situ of breast, longest in apocrine variety. The Breast 9: 23-27, 2000.
34. Rosenberg CL, de las Morenas A, Huang K, Cupples LA, Faller DV and Larson PS: Detection of monoclonal microsatellite alterations in atypical breast hyperplasia. J Clin Invest 98: 1095-1100, 1996.
35. WHO World Health Organization. International of Diseases for Oncology, 2nd edition. World Health Organization, Geneva, 1990.
36. UICC União Internacional Contra o Câncer: Classificação dos tumores malignos, 5° edição. Ministério da Saúde, Rio de Janeiro, Brasil, 1998.
37. Bloom MJC and Richardson WW: Histologic grading and prognosis in breast cancer: a study of 1709 cases. Br J Cancer 11: 358-377, 1957.
38. n Repeats in the Androgen Receptor Gene Using Polymerase Chain Reaction and Automated Fragment Analysis. Clin Biochem 32: 327-332, 1999.
39. Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S and Barrack ER: Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 3: 1599-1608, 1997.
40. Ribeiro ML, Santos A, Carvalho-Sales AB and Hackel C: Allelic frequencies of six polymorphic markers for risk of prostate cancer. Braz J Med Biol Res 35: 205-213, 2002.
41. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR and Quirke P: Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 67: 1262-1267, 1993.
42. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L and Yong EL: Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82: 3777-3782, 1997.
43. Keshgegian AA and Cnaan A: Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome. Arch Pathol Lab Med 120: 970-973, 1996.